ClinicalTrials.gov
public full text
Public Domain
Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma
The purpose of the study is to determine the clinical safety and operability of the innovative tissue imprint device ProTool.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma#804355
- Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas#855084
- A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme#884887
- Glioma "Liquid Biopsy": a new frontier in neurosurgery#955453
- Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma#127693
Record · ID 869928
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive